Qiangyuan Liu

发表

lncRNA uc.48+ regulates immune and inflammatory reactions mediated by the P2X7 receptor in type 2 diabetic mice

Hong Wu, Mei Jiang, Qiangyuan Liu, 2020, Experimental and therapeutic medicine.

Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells

P. Nambi, Qiangyuan Liu, E. Quinet, 2007, Molecular and Cellular Biochemistry.

Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.

Songwen Zhang, Qiangyuan Liu, Juan Wang, 2009, Journal of hepatology.

Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1.

N. Huang, P. Li, T. Cai, 2019 .

Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells

A. Dorner, P. Nambi, M. Evans, 2008, Journal of Translational Medicine.

Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.

Songwen Zhang, Juan Wang, Qiangyuan Liu, 2009, Biochemical and biophysical research communications.

Abstract 1453: LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in Cholesteryl Ester Transfer Protein-expressing species and inhibits atherosclerotic lesion progression in Low Density Lipoprotein receptor knockout mice

P. Nambi, J. Keith, R. Steffan, 2007 .

Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin αIIb cytoplasmic domain

G. Feuerstein, P. Nambi, Qiangyuan Liu, 2006 .

Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.

Farooq Azam, Anna Wilhelmsson, James Jetter, 2007, Bioorganic & medicinal chemistry.

Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.

Christopher Miller, Farooq Azam, Anna Wilhelmsson, 2006, Journal of medicinal chemistry.

LncRNA uc.48+ is involved in the diabetic immune and inflammatory responses mediated by P2X7 receptor in RAW264.7 macrophages.

Hong Wu, Mei Jiang, Qiangyuan Liu, 2018, International journal of molecular medicine.

Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin alphaIIb cytoplasmic domain.

G. Feuerstein, P. Nambi, Qiangyuan Liu, 2006, Biochemical pharmacology.

Tu-P8:325 Way-254011, a novel liver X receptor modulator, inhibitss atherosclerotic lesion progression in apolipoprotein E knockout mice

P. Nambi, J. Keith, Qiangyuan Liu, 2006 .